A Sharing Tool For Next-Gen Sequencing: FDA Launches precisionFDA
This article was originally published in The Gray Sheet
Executive Summary
As scheduled, FDA has launched its precisonFDA portal that the agency says will aggregate research data to help develop and verify next generation sequencing diagnostic tests.
You may also be interested in...
'App-A-Thon' Aims To Create PrecisionFDA Software Library To Advance Next-Gen Sequencing
US FDA is challenging stakeholders to develop apps that users of its precisionFDA platform can leverage to advance next-generation sequencing technology. Results from the competition will be announced by Commissioner Robert Califf next month in Washington, DC.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.